PPA
PMVP icon

Parametric Portfolio Associates’s PMV Pharmaceuticals PMVP Stock Holding History

Parametric Portfolio Associates’s Portfolio PMVP Stock Details PMVP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$969K Buy
46,528
+15,110
+48% +$267K ﹤0.01% 2795
2021
Q4 		$726K Buy
31,418
+3,273
+12% +$79.1K ﹤0.01% 2923
2021
Q3 		$839K Buy
28,145
+5,482
+24% +$175K ﹤0.01% 2878
2021
Q2 		$774K Buy
22,663
+1,694
+8% +$56.6K ﹤0.01% 2888
2021
Q1 		$690K Buy
20,969
+2,855
+16% +$113K ﹤0.01% 3335
2020
Q4 		$1.11M Buy
18,114
+7,351
+68% +$288K ﹤0.01% 2989
2020
Q3 		$382K Buy
+10,763
New +$396K ﹤0.01% 3381

Other funds holding PMVP

O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
IVM
InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
EC
Euclidean Capital New York $440M AUM 28.33% 1-Year Est. Return

Parametric Portfolio Associates's PMVP Position: Q1 2022 in Review

Parametric Portfolio Associates increased its PMV Pharmaceuticals (PMVP) stake by 48% in Q1 2022, buying an estimated $267K and bringing the position to 46,528 shares worth $969K. The position accounts for ﹤0.01% of the portfolio, ranked #2795.

Parametric Portfolio Associates first reported a position in PMVP in Q3 2020 and has held it in 7 quarters since. The position peaked at $1.11M in Q4 2020. 99 funds tracked by Wall St. Rank hold PMVP as of Q1 2022.

  • Parametric Portfolio Associates held 46,528 shares of PMV Pharmaceuticals worth $969K as of Q1 2022.
  • Parametric Portfolio Associates bought 15,110 PMV Pharmaceuticals shares in Q1 2022, an estimated $267K.
  • PMV Pharmaceuticals made up ﹤0.01% of Parametric Portfolio Associates's portfolio in Q1 2022, its #2795 holding.
  • Parametric Portfolio Associates first reported a position in PMV Pharmaceuticals in Q3 2020 and has held it in 7 quarters since.
  • Parametric Portfolio Associates's PMV Pharmaceuticals position peaked at $1.11M in Q4 2020.
  • 99 funds tracked by Wall St. Rank held PMV Pharmaceuticals as of Q1 2022.

Based on Parametric Portfolio Associates's 13F filing for Q1 2022, filed 16 May 2022.